The role of galectin in pancreatic, breast, colon, and thyroid cancer is unclear; in contrast, studies on gastric cancer revealed that it is impossible to use galectin 3 for clinical diagnostics as well as for prediction of disease recurrence and survival [32,33]. Here, LGALS3 is linked to gastric cancer.